Microenvironmental TFPI2 in Hirschsprung Disease: Mechanisms in ENCC Development

jpedsurg.org

Hirschsprung disease (HSCR) is a relatively common disorder in pediatric surgery, characterized by the absence of enteric ganglion cells due to defective colonization of enteric neural crest cells (ENCCs) in the intestine. This study aims to investigate alterations in the intestinal microenvironment, focusing on the tissue factor pathway inhibitor 2 (TFPI2) as a potential pathogenic factor.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Aug 2025 · 1 min read

In brief

This research examines how tissue factor pathway inhibitor 2 (TFPI2) in the intestinal microenvironment may contribute to Hirschsprung disease pathogenesis by affecting enteric neural crest cell development. The study explores molecular mechanisms underlying defective ENCC colonization that leads to absent enteric ganglia in this common pediatric surgical condition.

Hirschsprung disease results from failed enteric neural crest cell (ENCC) colonization, leading to absent ganglion cells in the intestine.
TFPI2 (tissue factor pathway inhibitor 2) in the intestinal microenvironment may play a pathogenic role in HSCR development.
Understanding microenvironmental factors like TFPI2 could reveal novel therapeutic targets beyond current surgical management of HSCR.
Defective ENCC migration and differentiation are central to HSCR pathophysiology, not just genetic mutations alone.
Research into intestinal microenvironment alterations may explain variable HSCR phenotypes and guide personalized treatment approaches.

Written by the GCMD Library team from the article.

Read it at the source ↗